HomeNewsBusinessCompaniesContinue to remain opportunistic for acquisitions: Sun Pharma

Continue to remain opportunistic for acquisitions: Sun Pharma

The merger between Sun and Ranbaxy achieved closure towards the end of March 2015.

June 07, 2016 / 08:55 IST
Story continues below Advertisement
first published: Jun 7, 2016 08:46 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!